A detailed history of Saratoga Research & Investment Management transactions in Becton Dickinson & CO stock. As of the latest transaction made, Saratoga Research & Investment Management holds 83,839 shares of BDX stock, worth $19.6 Million. This represents 0.89% of its overall portfolio holdings.

Number of Shares
83,839
Previous 87,135 3.78%
Holding current value
$19.6 Million
Previous $21.6 Million 9.12%
% of portfolio
0.89%
Previous 0.98%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 16, 2024

SELL
$225.07 - $246.17 $741,830 - $811,376
-3,296 Reduced 3.78%
83,839 $19.6 Million
Q1 2024

Apr 17, 2024

SELL
$233.45 - $247.73 $729,297 - $773,908
-3,124 Reduced 3.46%
87,135 $21.6 Million
Q4 2023

Feb 09, 2024

SELL
$232.24 - $267.23 $1.37 Million - $1.57 Million
-5,878 Reduced 6.11%
90,259 $22 Million
Q3 2023

Nov 09, 2023

SELL
$254.9 - $283.59 $19.4 Million - $21.5 Million
-75,951 Reduced 44.13%
96,137 $24.9 Million
Q2 2023

Jul 24, 2023

SELL
$238.39 - $265.32 $589,776 - $656,401
-2,474 Reduced 1.42%
172,088 $45.4 Million
Q1 2023

May 05, 2023

SELL
$229.71 - $259.35 $7.73 Million - $8.72 Million
-33,640 Reduced 16.16%
174,562 $43.2 Million
Q4 2022

Feb 13, 2023

SELL
$218.29 - $256.91 $1.01 Million - $1.19 Million
-4,636 Reduced 2.18%
208,202 $53 Million
Q3 2022

Oct 31, 2022

SELL
$51.03 - $264.23 $73,534 - $380,755
-1,441 Reduced 0.67%
212,838 $47.4 Million
Q2 2022

Aug 01, 2022

SELL
$234.74 - $275.42 $1.11 Million - $1.3 Million
-4,708 Reduced 2.15%
214,279 $52.8 Million
Q1 2022

Apr 29, 2022

SELL
$243.64 - $270.48 $326,721 - $362,713
-1,341 Reduced 0.61%
218,987 $58.3 Million
Q4 2021

Feb 08, 2022

SELL
$230.08 - $250.94 $91,801 - $100,125
-399 Reduced 0.18%
220,328 $55.4 Million
Q3 2021

Nov 05, 2021

BUY
$232.72 - $256.47 $5.88 Million - $6.48 Million
25,269 Added 12.93%
220,727 $54.3 Million
Q2 2021

Aug 10, 2021

BUY
$232.65 - $254.58 $12 Million - $13.1 Million
51,592 Added 35.86%
195,458 $47.5 Million
Q1 2021

Apr 12, 2021

BUY
$232.09 - $256.88 $11.9 Million - $13.2 Million
51,229 Added 55.3%
143,866 $35 Million
Q4 2020

Feb 03, 2021

BUY
$221.92 - $245.94 $4.27 Million - $4.74 Million
19,259 Added 26.25%
92,637 $23.2 Million
Q3 2020

Oct 09, 2020

SELL
$215.77 - $276.76 $879,046 - $1.13 Million
-4,074 Reduced 5.26%
73,378 $17.1 Million
Q2 2020

Aug 07, 2020

SELL
$219.9 - $263.41 $317,535 - $380,364
-1,444 Reduced 1.83%
77,452 $18.5 Million
Q1 2020

May 13, 2020

SELL
$195.69 - $279.01 $796,849 - $1.14 Million
-4,072 Reduced 4.91%
78,896 $18.1 Million
Q4 2019

Feb 05, 2020

SELL
$236.45 - $266.82 $907,258 - $1.02 Million
-3,837 Reduced 4.42%
82,968 $22.6 Million
Q3 2019

Oct 29, 2019

SELL
$230.58 - $256.08 $892,805 - $991,541
-3,872 Reduced 4.27%
86,805 $22 Million
Q2 2019

Jul 24, 2019

SELL
$217.4 - $246.08 $389,580 - $440,975
-1,792 Reduced 1.94%
90,677 $22.9 Million
Q1 2019

Apr 18, 2019

SELL
$206.05 - $248.17 $597,957 - $720,189
-2,902 Reduced 3.04%
92,469 $23.1 Million
Q4 2018

Jan 15, 2019

SELL
$204.73 - $257.93 $1.05 Million - $1.32 Million
-5,133 Reduced 5.11%
95,371 $21.5 Million
Q3 2018

Oct 15, 2018

SELL
$233.07 - $256.0 $1.13 Million - $1.25 Million
-4,867 Reduced 4.62%
100,504 $26.2 Million
Q2 2018

Jul 17, 2018

SELL
$208.1 - $233.85 $1.41 Million - $1.59 Million
-6,778 Reduced 6.04%
105,371 $25.2 Million
Q1 2018

May 01, 2018

SELL
$205.46 - $240.27 $1.05 Million - $1.22 Million
-5,094 Reduced 4.34%
112,149 $24.3 Million
Q4 2017

Jan 19, 2018

SELL
$189.0 - $222.64 $584,577 - $688,625
-3,093 Reduced 2.57%
117,243 $25.1 Million
Q3 2017

Oct 24, 2017

BUY
$186.89 - $198.9 $22.5 Million - $23.9 Million
120,336
120,336 $23.6 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $66.5B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Saratoga Research & Investment Management Portfolio

Follow Saratoga Research & Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Saratoga Research & Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Saratoga Research & Investment Management with notifications on news.